Superior vena cava syndrome: A radiation oncologist's perspective

Area of Science:

• Oncology
• Cardiology
• Thoracic Medicine

Background:

• Superior vena cava syndrome (SVCS) presents as a complex of symptoms due to superior vena cava obstruction.
• While benign causes exist, malignant etiologies are the predominant contributors to SVCS.
• Historically, SVCS was managed as a medical emergency.

Purpose of the Study:

• To review the evolving causes, symptoms, and pathophysiology of SVCS.
• To outline the contemporary management strategies for SVCS.
• To highlight the paradigm shift in SVCS treatment protocols.

Main Methods:

• Literature review of studies on superior vena cava syndrome.
• Analysis of historical and current management guidelines.
• Synthesis of data on causes, symptoms, pathophysiology, and treatment.

Main Results:

• Malignant causes are the primary drivers of SVCS.
• SVCS is no longer universally considered a medical emergency.
• Histological confirmation is now a prerequisite for treatment initiation.

Conclusions:

• The management of SVCS has significantly evolved.
• A diagnostic approach prioritizing histological confirmation is essential.
• Current policies reflect a less emergent, more diagnostically driven approach to SVCS.